• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    MindMed Has Productive End-Of-Phase 2 Meeting With FDA For MM120 In GAD

    20 Jun 2024 //

    BUSINESSWIRE

    BetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivatives

    27 Sep 2022 //

    GLOBENEWSWIRE

    MindMed Shows Publication of Study Comparing Acute Effects of LSD and Psilocybin

    02 Mar 2022 //

    PRNEWSWIRE

    BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity

    15 Feb 2022 //

    GLOBENEWSWIRE

    BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder (MDD) Treatment With BETR-001

    20 Jan 2022 //

    PRESS RELEASE

    MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult ADHD

    17 Dec 2021 //

    PRNEWSWIRE

    BetterLife Enters Research Agreement with Medical College Wisconsin for TD-0148A

    09 Sep 2021 //

    PRESS RELEASE

    Mindset Announce Availability of 1st Preclinical Psychedelic Benchmark Data

    14 Jun 2021 //

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.